ATE393626T1 - Transnasale anticonvulsive zusammensetzungen - Google Patents

Transnasale anticonvulsive zusammensetzungen

Info

Publication number
ATE393626T1
ATE393626T1 AT00947610T AT00947610T ATE393626T1 AT E393626 T1 ATE393626 T1 AT E393626T1 AT 00947610 T AT00947610 T AT 00947610T AT 00947610 T AT00947610 T AT 00947610T AT E393626 T1 ATE393626 T1 AT E393626T1
Authority
AT
Austria
Prior art keywords
compositions
transnasal anticonvulsive
transnasal
anticonvulsive compositions
anticonvulsive
Prior art date
Application number
AT00947610T
Other languages
English (en)
Inventor
Yong-Moon Choi
Lianli Li
Kwon-Ho Kim
Original Assignee
Sk Holdings Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Holdings Co Ltd filed Critical Sk Holdings Co Ltd
Application granted granted Critical
Publication of ATE393626T1 publication Critical patent/ATE393626T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00947610T 1999-07-26 2000-07-24 Transnasale anticonvulsive zusammensetzungen ATE393626T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14559099P 1999-07-26 1999-07-26

Publications (1)

Publication Number Publication Date
ATE393626T1 true ATE393626T1 (de) 2008-05-15

Family

ID=22513768

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00947610T ATE393626T1 (de) 1999-07-26 2000-07-24 Transnasale anticonvulsive zusammensetzungen

Country Status (16)

Country Link
US (2) US6627211B1 (de)
EP (1) EP1196156B1 (de)
JP (1) JP4951723B2 (de)
KR (1) KR100715513B1 (de)
CN (1) CN1200697C (de)
AR (1) AR031072A1 (de)
AT (1) ATE393626T1 (de)
AU (1) AU778896B2 (de)
CA (1) CA2379365C (de)
DE (1) DE60038738T2 (de)
ES (1) ES2304969T3 (de)
MX (1) MXPA02001612A (de)
MY (1) MY124195A (de)
RU (1) RU2264209C2 (de)
TW (1) TWI269652B (de)
WO (1) WO2001006987A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2304969T3 (es) * 1999-07-26 2008-11-01 Sk Holdings Co., Ltd. Composiciones anticonvulsivas transnasales.
CN100421649C (zh) * 2003-06-17 2008-10-01 Sk株式会社 含地西泮的经鼻微乳
GB0321607D0 (en) * 2003-09-15 2003-10-15 Vectura Ltd Manufacture of pharmaceutical compositions
GB0400804D0 (en) 2004-01-14 2004-02-18 Innoscience Technology Bv Pharmaceutical compositions
ES2342185T3 (es) * 2004-09-16 2010-07-02 Janssen Pharmaceutica Nv Uso de (di)carbamatos de 2-fenil-1,2-etanodiol para el tratamiento de la epileptogenesis.
KR20060030175A (ko) * 2004-10-05 2006-04-10 경북대학교 산학협력단 무정위성 운동 치료용 약학조성물
US8911751B2 (en) * 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
WO2007043057A2 (en) * 2005-10-11 2007-04-19 Yissum, Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
TW200824693A (en) 2006-08-28 2008-06-16 Jazz Pharmaceuticals Inc Pharmaceutical compositions of clonazepam and methods of use thereof
US7745430B2 (en) * 2006-11-15 2010-06-29 Sk Holdings Co., Ltd. Transnasal anticonvulsive pharmaceutical composition
US20080275030A1 (en) * 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
CN101678112B (zh) * 2007-01-19 2016-08-31 哈南亚有限公司 用于递送治疗剂的方法和组合物
US8530463B2 (en) * 2007-05-07 2013-09-10 Hale Biopharma Ventures Llc Multimodal particulate formulations
US20080279784A1 (en) * 2007-05-07 2008-11-13 Questcor Pharmaceuticals, Inc. Nasal administration of benzodiazepines
TW200922635A (en) * 2007-08-31 2009-06-01 Archimedes Dev Ltd Non-aqueous pharmaceutical compositions
EP2030610A1 (de) * 2007-08-31 2009-03-04 Archimedes Development Limited Nichtwässrige pharmazeutische Zusammensetzungen
US8507468B2 (en) * 2007-10-02 2013-08-13 Robert Orr Intranasal anti-convulsive compositions and methods
RU2370260C1 (ru) * 2008-03-17 2009-10-20 Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) (статус государственного учреждения) Противосудорожное средство
CA2756690C (en) 2008-03-28 2016-08-16 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
KR101517415B1 (ko) 2008-05-14 2015-05-07 에스케이바이오팜 주식회사 난용성 항경련제를 함유하는 경비 항경련성 약학 조성물
AU2012236334B2 (en) * 2011-03-31 2017-02-16 Sk Biopharmaceuticals Co., Ltd. Intranasal benzodiazepine pharmaceutical compositions
US20140128379A1 (en) * 2011-04-01 2014-05-08 Cpex Pharmaceuticals, Inc. Nasal formulations of benzodiazepine
EP4085899A1 (de) 2011-06-14 2022-11-09 Neurelis, Inc. Verabreichung von benzodiazepin
CN102836125A (zh) * 2011-06-23 2012-12-26 王晓青 治疗低血容量休克的丙戊酸及其盐的鼻腔给药制剂
JP2015227288A (ja) * 2012-08-31 2015-12-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 けいれん重積発作の治療用医薬組成物
EP2958593B1 (de) * 2013-02-22 2021-05-12 Eastgate Pharmaceuticals Inc. Pharmazeutische zusammensetzung zur transmukosalen verabreichung von lorazepam
WO2017085687A1 (en) 2015-11-20 2017-05-26 West-Ward Pharmaceuticals International Limited Stable formulation of phenobarbital sodium injection
EP3681474B1 (de) 2017-09-11 2025-10-29 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Zusammensetzungen und verfahren zur nasalen verabreichung von medikamenten an das gehirn und zur systemischen wirkung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3767615D1 (de) 1986-03-10 1991-02-28 Kurt Burghart Pharmazeutikum sowie verfahren zu seiner herstellung.
US4950664A (en) 1988-09-16 1990-08-21 Rugby-Darby Group Companies, Inc. Nasal administration of benzodiazepine hypnotics
WO1991016929A1 (en) * 1990-05-10 1991-11-14 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
RU2118537C1 (ru) * 1995-10-02 1998-09-10 Государственный научный центр социальной и судебной психиатрии им.В.П.Сербского Способ лечения больных эпилепсией
AU5155198A (en) * 1997-08-28 1999-03-22 Robert Murdock Method and composition for transdermal administration of pharmacologic agent
ES2304969T3 (es) * 1999-07-26 2008-11-01 Sk Holdings Co., Ltd. Composiciones anticonvulsivas transnasales.

Also Published As

Publication number Publication date
CN1364079A (zh) 2002-08-14
KR100715513B1 (ko) 2007-05-08
MY124195A (en) 2006-06-30
AR031072A1 (es) 2003-09-10
EP1196156A2 (de) 2002-04-17
WO2001006987A3 (en) 2002-01-24
US7132112B2 (en) 2006-11-07
DE60038738D1 (de) 2008-06-12
MXPA02001612A (es) 2003-10-14
AU6118500A (en) 2001-02-13
CA2379365C (en) 2009-11-17
AU778896B2 (en) 2004-12-23
CN1200697C (zh) 2005-05-11
RU2002104970A (ru) 2004-01-10
RU2264209C2 (ru) 2005-11-20
ES2304969T3 (es) 2008-11-01
TWI269652B (en) 2007-01-01
WO2001006987A2 (en) 2001-02-01
JP4951723B2 (ja) 2012-06-13
DE60038738T2 (de) 2009-07-02
KR20020059583A (ko) 2002-07-13
EP1196156A4 (de) 2005-01-12
US6627211B1 (en) 2003-09-30
US20040028617A1 (en) 2004-02-12
JP2003505403A (ja) 2003-02-12
EP1196156B1 (de) 2008-04-30
CA2379365A1 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
DE60038738D1 (de) Transnasale anticonvulsive zusammensetzungen
AR023440A1 (es) Composiciones antitranspirantes
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
FI20105657L (fi) Farmaseuttisia koostumuksia
PT1242087E (pt) Composicoes farmaceuticas
DE60020342D1 (de) Tiefeindringende antimikrobielle zusammensetzungen
ITMI20010748A0 (it) Composizioni farmaceutiche
IS6120A (is) Lyfjablanda
ATE303787T1 (de) Schergelzusammensetzungen
AR027896A1 (es) Composiciones valdecoxib
AR028197A1 (es) Composiciones antitranspirantes
EA199900373A3 (ru) Фармацевтические композиции
ITMI991754A0 (it) Composizioni cosmetiche
ID29785A (id) Komposisi-komposisi sampo
ATE257691T1 (de) Schweisshemmende zusammensetzungen
DE60007530D1 (de) Oral wirksame androgene
DE60025624D1 (de) Farbstabile polyarylat enthaltende zusammensetzungen
ATE369830T1 (de) Schweisshemmende zusammensetzungen
NO20026123L (no) Farmasöytiske sammensetninger
IS6398A (is) Lyfjablöndur
ATE314049T1 (de) Schweisshemmende zusammensetzungen
DE60021259D1 (de) Reinigungsmittelzusammensetzungen
DE69943245D1 (de) Gaserzeugende zusammensetzung
PT1239832E (pt) Composicoes farmaceuticas
NO20031095L (no) Farmasoytiske sammensetninger

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties